AP - Pfizer Inc. said Friday it named Vice Chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, 63, who will remain chairman of the board of the world's largest drug company until his retirement in February 2007.

Reuters - Pfizer Inc.'s board of directors was meeting on Friday to discuss plans for picking a successor to the company's chairman and chief executive, Hank McKinnell, who is scheduled to retire in February 2008.

Pfizer beat analyst expectations on Thursday when its earnings jumped for the second quarter as sales surged, led by the world's top-selling drug, Lipitor. The stock price for Pfizer, the world's biggest drug maker, rose more than 2 percent in morning trading....

Reuters - Pfizer Inc. on Thursday said second-quarter earnings from continuing operations rose on higher sales of its prescription drugs.

Multiple lawsuits have been filed against Pfizer in connection with its drug, Lipitor. Friday, 17 personal injury cases were filed in the New York State Supreme Court, by plaintiffs in California, Connecticut, Massachusetts, Michigan, New Jersey, New York and Virginia, claiming the drug caused...

AP - Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and Merck & Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.

AP - Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and Merck & Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.

Global pharmaceutical giant Pfizer Inc. on Thursday announced its intention to introduce a generic version of its antidepressant Zoloft. The move is spurred by the arrival of a competitor's brand scheduled to hit the U.S. drug market by the weekend....

Global pharmaceutical giant Pfizer Inc. says the United Kingdom's Court of Appeal has maintained a previous ruling in favor of the exclusivity of the main patent covering atorvastatin, the active ingredient in Lipitor.

Reuters - Johnson & Johnson said on Monday it would buy Pfizer Inc.'s consumer health-care business for $16.6 billion in cash to increase its lead in the market for non-prescription health products.

AP - Johnson & Johnson said Monday it is buying Pfizer Inc.'s consumer health care unit for $16.6 billion in a nearly all-cash deal that strongly boosts J&J's smallest division.

Global pharmaceutical giant Pfizer Inc. announced on Monday it has agreed sell its consumer health care unit to Johnson & Johnson for $16.6 billion.

Reuters - Pfizer Inc. said on Monday it had reached a definitive agreement to sell its consumer healthcare business to Johnson & Johnson for $16.6 billion in cash.

Reuters - Johnson & Johnson is close to reaching a deal to buy the consumer products unit of Pfizer, which includes brands like Listerine and Sudafed, for more than $16 billion, The New York Times online edition reported on Sunday.

Reuters - Johnson & Johnson is close to reaching a deal to buy the consumer product unit of Pfizer , which includes brands like Listerine and Sudafed, for more than $16 billion, The New York Times online edition reported on Sunday.

Zocor, a cholesterol-cutting drug from Merck and Zoloft, antidepressant from Pfizer are going off patent this month. Merck's patent for Zocor expires Friday while Zoloft loses patent protection on June 30.

AP - It's a novel approach in the long battle between brand name drugs and their generic rivals: Merck & Co. is slashing the price of its cholesterol drug Zocor so low for one insurance plan that members will actually pay less for the original pills than for the generic.

AFP - Chinese drug firms have appealed a court ruling upholding US pharmaceutical giant Pfizer's China patent for its impotency drug Viagra, both sides have said.

Reuters - GE Healthcare said on Tuesday it had made a recommended 3.22 billion Swedish crown ($436.3 million) cash offer for Swedish medical instruments maker Biacore .

AP - Twelve Chinese pharmaceutical companies are appealing a court ruling that sides with Pfizer Inc. and prevents local drug makers from selling generic versions of Viagra, a state-run newspaper said Tuesday.